focus -WSS

focus

author：leisure time 2025-09-27 15:58:05 - browse：4

CDC campus exterior -- first opinion coverage from STAT — ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Biden administration opens offers in Medicare drug price negotiations

hotspot

explore

WSS

Quicker fix for pulse oximeters urged during FDA public meeting

Woodcock on FDA’s accelerated approval and her next chapter

Quicker fix for pulse oximeters urged during FDA public meeting

Do digital therapeutics have a future in medicine?

The real point of Kenneth Smith’s execution by nitrogen gas

Biden administration opens offers in Medicare drug price negotiations

focus

focus

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Time to name cancers by genetics, not organ of origin, expert says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

General Catalyst, Summa Health deal will turn on physician buy

In age of alternative facts, a scholarly course on calling out crap

The real point of Kenneth Smith’s execution by nitrogen gas

Jerome Adams on the need for new antivirals for Covid

Vertex non

Novavax promises a turnaround & Lilly roils the obesity market

Vertigo drug brings hope for rare neuron disorder, Niemann

leisure time

New Ultima Genomics DNA sequencer can read genome for $100

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

New Ultima Genomics DNA sequencer can read genome for $100

Time to name cancers by genetics, not organ of origin, expert says

Quicker fix for pulse oximeters urged during FDA public meeting

Wikipedia

hotspot

explore

focus